vs
CSW INDUSTRIALS, INC.（CSW）与MADRIGAL PHARMACEUTICALS, INC.（MDGL）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是CSW INDUSTRIALS, INC.的1.4倍（$321.1M vs $233.0M），CSW INDUSTRIALS, INC.净利率更高（4.4% vs -18.2%，领先22.6%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 20.3%），CSW INDUSTRIALS, INC.自由现金流更多（$22.7M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
CSW vs MDGL — 直观对比
营收规模更大
MDGL
是对方的1.4倍
$233.0M
营收增速更快
MDGL
高出190.4%
20.3%
净利率更高
CSW
高出22.6%
-18.2%
自由现金流更多
CSW
多$156.6M
$-133.8M
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $233.0M | $321.1M |
| 净利润 | $10.3M | $-58.6M |
| 毛利率 | 39.7% | — |
| 营业利润率 | 7.4% | -18.6% |
| 净利率 | 4.4% | -18.2% |
| 营收同比 | 20.3% | 210.8% |
| 净利润同比 | -61.9% | 1.4% |
| 每股收益（稀释后） | $0.62 | $-2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSWMDGL
| Q4 25 | $233.0M | $321.1M | ||
| Q3 25 | $277.0M | $287.3M | ||
| Q2 25 | $263.6M | $212.8M | ||
| Q1 25 | $230.5M | $137.3M | ||
| Q4 24 | $193.6M | $103.3M | ||
| Q3 24 | $227.9M | $62.2M | ||
| Q2 24 | $226.2M | — | ||
| Q1 24 | $210.9M | $0 |
净利润CSWMDGL
| Q4 25 | $10.3M | $-58.6M | ||
| Q3 25 | $40.7M | $-114.2M | ||
| Q2 25 | $40.9M | $-42.3M | ||
| Q1 25 | $35.1M | $-73.2M | ||
| Q4 24 | $26.9M | $-59.4M | ||
| Q3 24 | $36.1M | $-107.0M | ||
| Q2 24 | $38.6M | — | ||
| Q1 24 | $31.8M | $-147.5M |
毛利率CSWMDGL
| Q4 25 | 39.7% | — | ||
| Q3 25 | 43.0% | — | ||
| Q2 25 | 43.8% | — | ||
| Q1 25 | 44.2% | 96.7% | ||
| Q4 24 | 41.4% | — | ||
| Q3 24 | 45.6% | — | ||
| Q2 24 | 47.5% | — | ||
| Q1 24 | 44.4% | — |
营业利润率CSWMDGL
| Q4 25 | 7.4% | -18.6% | ||
| Q3 25 | 20.5% | -39.7% | ||
| Q2 25 | 20.8% | -22.2% | ||
| Q1 25 | 19.5% | -57.8% | ||
| Q4 24 | 15.3% | -64.8% | ||
| Q3 24 | 22.6% | -187.1% | ||
| Q2 24 | 24.3% | — | ||
| Q1 24 | 21.0% | — |
净利率CSWMDGL
| Q4 25 | 4.4% | -18.2% | ||
| Q3 25 | 14.7% | -39.8% | ||
| Q2 25 | 15.5% | -19.9% | ||
| Q1 25 | 15.2% | -53.4% | ||
| Q4 24 | 13.9% | -57.5% | ||
| Q3 24 | 15.8% | -172.0% | ||
| Q2 24 | 17.1% | — | ||
| Q1 24 | 15.1% | — |
每股收益（稀释后）CSWMDGL
| Q4 25 | $0.62 | $-2.55 | ||
| Q3 25 | $2.41 | $-5.08 | ||
| Q2 25 | $2.43 | $-1.90 | ||
| Q1 25 | $2.05 | $-3.32 | ||
| Q4 24 | $1.60 | $-2.50 | ||
| Q3 24 | $2.26 | $-4.92 | ||
| Q2 24 | $2.47 | — | ||
| Q1 24 | $2.03 | $-7.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.2M | $198.7M |
| 总债务越低越好 | — | $339.9M |
| 股东权益账面价值 | $1.1B | $602.7M |
| 总资产 | $2.3B | $1.3B |
| 负债/权益比越低杠杆越低 | — | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资CSWMDGL
| Q4 25 | $40.2M | $198.7M | ||
| Q3 25 | $31.5M | $295.7M | ||
| Q2 25 | $38.0M | $186.2M | ||
| Q1 25 | $225.8M | $183.6M | ||
| Q4 24 | $213.8M | $100.0M | ||
| Q3 24 | $273.2M | $232.7M | ||
| Q2 24 | $18.9M | — | ||
| Q1 24 | $22.2M | $622.5M |
总债务CSWMDGL
| Q4 25 | — | $339.9M | ||
| Q3 25 | — | $339.8M | ||
| Q2 25 | — | $118.4M | ||
| Q1 25 | $800.1M | $118.0M | ||
| Q4 24 | — | $117.6M | ||
| Q3 24 | — | $117.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | $166.0M | $116.1M |
股东权益CSWMDGL
| Q4 25 | $1.1B | $602.7M | ||
| Q3 25 | $1.1B | $625.7M | ||
| Q2 25 | $1.1B | $696.0M | ||
| Q1 25 | $1.1B | $710.6M | ||
| Q4 24 | $1.0B | $754.4M | ||
| Q3 24 | $1.0B | $777.2M | ||
| Q2 24 | $650.2M | — | ||
| Q1 24 | $615.7M | $850.8M |
总资产CSWMDGL
| Q4 25 | $2.3B | $1.3B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.5B | $1.0B | ||
| Q1 25 | $1.4B | $996.6M | ||
| Q4 24 | $1.4B | $1.0B | ||
| Q3 24 | $1.4B | $1.1B | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.0B | $1.1B |
负债/权益比CSWMDGL
| Q4 25 | — | 0.56× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | 0.75× | 0.17× | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.27× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.9M | $-133.5M |
| 自由现金流经营现金流 - 资本支出 | $22.7M | $-133.8M |
| 自由现金流率自由现金流/营收 | 9.8% | -41.7% |
| 资本支出强度资本支出/营收 | 2.6% | 0.1% |
| 现金转化率经营现金流/净利润 | 2.81× | — |
| 过去12个月自由现金流最近4个季度 | $162.0M | — |
8季度趋势，按日历期对齐
经营现金流CSWMDGL
| Q4 25 | $28.9M | $-133.5M | ||
| Q3 25 | $61.8M | $79.8M | ||
| Q2 25 | $60.6M | $-47.1M | ||
| Q1 25 | $27.3M | $-88.9M | ||
| Q4 24 | $11.6M | $-104.5M | ||
| Q3 24 | $66.8M | $-67.0M | ||
| Q2 24 | $62.7M | — | ||
| Q1 24 | $22.4M | $-149.2M |
自由现金流CSWMDGL
| Q4 25 | $22.7M | $-133.8M | ||
| Q3 25 | $58.7M | $79.0M | ||
| Q2 25 | $57.7M | — | ||
| Q1 25 | $22.8M | — | ||
| Q4 24 | $8.5M | $-104.7M | ||
| Q3 24 | $61.3M | $-67.8M | ||
| Q2 24 | $59.6M | — | ||
| Q1 24 | $17.5M | $-149.5M |
自由现金流率CSWMDGL
| Q4 25 | 9.8% | -41.7% | ||
| Q3 25 | 21.2% | 27.5% | ||
| Q2 25 | 21.9% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 4.4% | -101.3% | ||
| Q3 24 | 26.9% | -109.0% | ||
| Q2 24 | 26.3% | — | ||
| Q1 24 | 8.3% | — |
资本支出强度CSWMDGL
| Q4 25 | 2.6% | 0.1% | ||
| Q3 25 | 1.1% | 0.3% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 2.0% | 0.0% | ||
| Q4 24 | 1.6% | 0.2% | ||
| Q3 24 | 2.4% | 1.3% | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 2.3% | — |
现金转化率CSWMDGL
| Q4 25 | 2.81× | — | ||
| Q3 25 | 1.52× | — | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 0.71× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
